Acadia Pharmaceuticals Inc (ACAD): Total Liabilities
$336.81M
As of 2025-12-31
$436.29M
As of 2026-06-30
+21.6%
3-year compound annual growth
+16.7%
5-year compound annual growth
+31.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $336.81M | -26.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $454.96M | +43.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $317.20M | +69.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $187.40M | +17.7% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $159.23M | +2.3% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $155.61M | +85.1% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $84.05M | +37.5% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $61.12M | +24.2% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $49.22M | +15.2% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $42.74M | +93.1% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $22.13M | +38.6% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $15.97M | +128.6% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $6.99M | +17.5% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $5.95M | -32.0% | 2014-02-27, Balance as of period end |
| 2011-12-31 | $8.75M | +0.5% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $8.71M | n/a | 2012-03-06, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $336.81M | -26.0% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.61B | +2.5% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $656.90M | +128.2% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.03B | +25.6% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.30B | -21.3% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $899.65M | +5.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $401.41M | +18.0% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.36B | -5.5% |
| Alkermes plc. (ALKS) | 2025-12-31 | $667.70M | +13.1% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗